pharma · Colitis, Ulcerative · Multiple Myeloma
Janssen Cilag International
Janssen Cilag International NV
Janssen Cilag International clinical programs — 5 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- São Paulo, EU
- Employees
- 13
- Programs
- 46
- Drugs
- 37
- Patents
- 0
Janssen Cilag International projects
5 ClinicalTrials.gov programs sponsored by Janssen Cilag International.
Janssen Cilag International has 5 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Acetaminophen
Janssen Cilag International NV
Healthy
1 trial -
Ad26.COV2.S
Janssen Cilag International NV
Healthy
1 trial -
Hydromorphone 16 mg
Janssen Cilag International NV
Healthy Volunteers
1 trial -
JNJ-53718678
Janssen Cilag International NV
Respiratory Syncytial Virus Infections
1 trial -
JNJ-56021927
Janssen Cilag International NV
Prostatic Neoplasms, Castration-Resistant
1 trial
Frequently asked questions
How many clinical projects does Janssen Cilag International have?
5 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.